1-3 of 3
James A Child
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Disease (MRD) in Myeloma: Independent Outcome Prediction and Sequential Survival Benefits per Log Tumour Reduction

Andy C Rawstron, BSc, PhD, Walter Gregory, PhD, Ruth M de Tute, Faith E Davies, MD, Susan E Bell, DPhil, Mark T Drayson, MDPhD, Gordon Cook, MD, Graham H Jackson, MD, James A Child, Gareth J. Morgan, MD PhD, Roger G Owen
Journal: Blood
Blood (2014) 124 (21): 3416.
https://doi.org/10.1182/blood.V124.21.3416.3416
Published: 2014
Journal Articles

Maintenance Thalidomide May Improve Progression Free but Not Overall Survival; Results from the Myeloma IX Maintenance Randomisation

Gareth J Morgan, MD, PhD, Graham H Jackson, Faith E Davies, MD, Mark T Drayson, Roger G Owen, Walter M Gregory, Dena C Cohen, Alex J. Szubert, Susan E Bell, Fiona Ross, James A Child
Journal: Blood
Blood (2008) 112 (11): 656.
https://doi.org/10.1182/blood.V112.11.656.656
Published: 2008
Journal Articles

Thalidomide Combinations Improve Response Rates; Results from the MRC IX Study.

Gareth J. Morgan, MD, PhD, Faith E. Davies, MD, Roger G. Owen, MD, Andrew C. Rawstron, PhD, Sue Bell, DPhil, Kim Cocks, MSc, Walter Gregory, Graham Jackson, MD, Mark T. Drayson, PhD, Matthew W. Jenner, MD, James A. Child, MD
Journal: Blood
Blood (2007) 110 (11): 3593.
https://doi.org/10.1182/blood.V110.11.3593.3593
Published: 2007